GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lipum AB (OSTO:LIPUM) » Definitions » Current Deferred Taxes Liabilities

Lipum AB (OSTO:LIPUM) Current Deferred Taxes Liabilities : kr0.00 Mil (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Lipum AB Current Deferred Taxes Liabilities?

Current Deferred Taxes Liabilities represent future tax liabilities, resulting from temporary differences between book (accounting) value of assets and liabilities and their tax value, or timing differences between the recognition of gains and losses in financial statements and their recognition in a tax computation. Deferred tax liabilities generally arise where tax relief is provided in advance of an accounting expense, or income is accrued but not taxed until received.

Lipum AB's current deferred tax liabilities for the quarter that ended in Sep. 2024 was kr0.00 Mil.

Lipum AB Current Deferred Taxes Liabilities Historical Data

The historical data trend for Lipum AB's Current Deferred Taxes Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lipum AB Current Deferred Taxes Liabilities Chart

Lipum AB Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Current Deferred Taxes Liabilities
- - - - -

Lipum AB Quarterly Data
Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Current Deferred Taxes Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Lipum AB Current Deferred Taxes Liabilities Related Terms

Thank you for viewing the detailed overview of Lipum AB's Current Deferred Taxes Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Lipum AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lipum AB (OSTO:LIPUM) » Definitions » Current Deferred Taxes Liabilities
Comparable Companies
OSTO:XBRANE OSTO:GUARD OSTO:KDEV OSTO:ANNX OSTO:NXTCL OSTO:ACE OSTO:CLBIO XSAT:CURAS OSTO:ALZ OSTO:XINT VRTX ASX:CSL REGN XKRX:207940 XBRU:UCB XBRU:ARGX ALNY BNTX XKRX:068270 BGNE
Traded in Other Exchanges
N/A
Address
Tvistevagen 48 C, Umea, SWE, 907 36
Website
https://www.lipum.se
Lipum AB is a clinical-stage biopharmaceutical company specializing in the discovery and development of a novel treatment for chronic inflammatory diseases. The candidate SOL-116 is a humanized antibody designed to provide efficacious therapy by blocking a previously overlooked target molecule (BSSL) of the immune system. The development is supported by solid pre-clinical data for rheumatoid arthritis. Lipum also explores other inflammatory diseases with a high unmet medical need.

Lipum AB Headlines

No Headlines